Milan
Facility
Cell Therapy & Viral Vector Manufacturing in Europe
AGC Biologics Milan specializes in cell therapy and viral vector development and manufacturing. The site works with virtually any cell type and lentiviral, retroviral, and adeno‐ associated viral vectors. The facility was the first cell and gene therapy site approved in Europe for GMP manufacturing of clinical and commercial supplies. The core scientific team has more than 25 years of expertise in the field and unique knowledge you will not find anywhere else.
Got a project? Let's talk.
Get all the details on this site.
Our in-depth fact sheet provides all the details you need on the complete capabilities and services of this campus and its abilities to support your next project.
DOWNLOAD NOWMilan Facility Highlights
Hover over each card to learn more
Milan Facility Highlights
Tap on each card to learn more
Cell Therapy Development & Manufacturing
Our cell therapy services can help at any stage, from initial development to full commercial supply. We have GMP manufacturing suites for cell therapy practice in one centralized location where all processes are managed. Using both autologous and allogeneic systems; our team has extensive experience with T cell, HSC / CD34, and NK cell products.
Viral Vector Development & Manufacturing
Our new standardized platforms BravoAAV™ and ProntoLVV™ offer an innovative templated approach to AAV and LVV manufacturing. With prequalified scale-down models simplifying and accelerating the path to commercialization, our Milan site can take on any project. We have commercial manufacturing experience with three viral vector products, and 5 PPQ runs completed to support BLA filings.
Viral Vector CapabilitiesAnalytical Development
Our globally aligned quality systems feature a full docket of site-specific processes, specifications, and records, with over 160 analytical tests and 95% of release testing provided in-house including sterility, RCL and adventitious agents.
Fill & Finish
We have the FC-800 O-Rabs filling machine onsite, with capabilities to fill 6R Type I Glass vials and polymeric vials (e.g. COP) with a volume up to 8mL. Max n° of vials filled per batch: 1350 (MF covered). Filling speed: 500 vials/h 100% IPC, 800 vials/h without IPC.
Watch our Milan Facility Expansion Tour
Milan
T: +39-02-21277-1
F: +39-02-21277-325
E: contactus@agcbio.com
Openzone
Via Meucci, 3
20091 Bresso (MI), Italy
Join our team!
AGC Biologics S.p.A.,
Registered office: via Meucci 3, 20091 Bresso (MI)
Share capital: € 21.819.020,83 i.v.
REA n.1506630 - Milan Companies' Register/C.F./P.IVA no. 11887610159
Sole shareholder company subject to the management and coordination of AGC Inc.